Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jul 31, 2025 | (Q4)Jul 31, 2025 | (Q3)Apr 30, 2025 | (Q2)Jan 31, 2025 | (Q1)Oct 31, 2024 | (FY)Jul 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | -179.98%-4.05M | -2.55M | 698K | -1.16M | 82.97%-1.04M | -51.26%5.06M | 520.69%3.06M | 139.29%998K | -6.09M | 143.86%10.38M |
| Net profit before non-cash adjustment | 127.33%8.14M | --3.28M | --1.63M | --1.9M | 116.96%1.33M | -117.16%-29.79M | -26.19%465K | -2,342.61%-13.05M | ---7.86M | -405.98%-13.72M |
| Total adjustment of non-cash items | -97.01%636K | --57K | --185K | --530K | -101.60%-136K | -21.68%21.25M | 238.55%230K | 1,987.42%12.44M | --8.49M | 2,720.88%27.14M |
| -Depreciation and amortization | -39.09%565K | --146K | --155K | --144K | -9.77%120K | 18.59%927.65K | 32.52%163K | 13.71%141K | --133K | 66.43%782.21K |
| -Reversal of impairment losses recognized in profit and loss | 63.18%-128K | ---- | ---- | ---- | ---281K | -109.13%-347.59K | --0 | ---- | ---- | 1,324.61%3.81M |
| -Share of associates | ---- | ---- | ---- | ---- | ---- | -99.81%22.31K | --0 | -66.54%178K | ---156K | 1,595.23%11.54M |
| -Disposal profit | ---- | ---- | ---- | ---- | ---- | 93.34%20.65M | ---14K | --12.18M | --8.46M | --10.68M |
| -Net exchange gains and losses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| -Other non-cash items | 43,173.59%199K | --39K | --30K | --105K | -50.98%25K | -100.14%-462 | 15.71%81K | 221.67%73K | --51K | 162.77%320.58K |
| Changes in working capital | -194.31%-12.83M | ---5.89M | ---1.11M | ---3.59M | 66.61%-2.23M | 547.65%13.6M | 8,055.17%2.37M | 143.28%1.61M | ---6.69M | -155.31%-3.04M |
| -Change in receivables | -159.40%-11.57M | ---2.66M | --619K | ---1.4M | -776.48%-8.13M | 539.60%19.47M | -137.38%-502K | 32.93%-3.44M | ---927K | -1,538.06%-4.43M |
| -Change in inventory | 139.50%195K | ---3.61M | --821K | ---568K | 3,480.95%3.55M | 48.85%-493.73K | 53.85%280K | 729.12%1.51M | ---105K | -161.17%-965.21K |
| -Change in payables | 84.40%-623K | --600K | ---675K | ---2.18M | 2.00%1.64M | -367.72%-3.99M | 198.06%1.32M | -390.85%-4.67M | --1.6M | 181.00%1.49M |
| -Changes in other current assets | 39.81%-832K | ---224K | ---1.88M | --564K | 109.72%706K | -259.95%-1.38M | 920.65%1.27M | 2,290.93%8.22M | ---7.26M | 170.03%864.16K |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | ||||||||||
| Interest paid (cash flow from operating activities) | 55.05%-290K | -58K | -54K | -136K | 40.00%-42K | 14.96%-645.22K | -34.15%-110K | -52.54%-90K | -70K | -161.64%-758.76K |
| Interest received (cash flow from operating activities) | -72.60%91K | 19K | 24K | 31K | -10.53%17K | 115.74%332.13K | 141.67%29K | -85.71%17K | 19K | -8.36%153.95K |
| Tax refund paid | 16.96%-2.96M | -723K | -1.15M | -295K | -127.92%-800K | -27.12%-3.57M | -26.84%-860K | -1.22%-248K | -351K | -61.17%-2.81M |
| Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating cash flow | -712.73%-7.21M | ---3.32M | ---478K | ---1.56M | 71.31%-1.86M | -83.11%1.18M | 930.98%2.12M | 124.84%677K | ---6.49M | 191.23%6.97M |
| Investing cash flow | ||||||||||
| Net PPE purchase and sale | 67.64%-121K | ---16K | ---58K | ---3K | ---44K | -267.16%-373.94K | -2,125.00%-445K | ---- | ---- | -69.74%-101.84K |
| Net intangibles purchase and sale | ---- | ---- | ---- | ---- | ---- | ---180K | ---- | ---- | ---- | ---- |
| Net business purchase and sale | ---- | ---- | ---- | ---- | ---- | --440K | --0 | ---- | ---- | ---- |
| Net investment product transactions | ---- | ---- | ---- | ---- | ---- | --312.19K | --0 | ---- | ---- | ---- |
| Advance cash and loans provided to other parties | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 |
| Repayment of advance payments to other parties and cash income from loans | ---- | ---- | ---- | ---- | ---- | -33.33%1M | ---- | ---- | ---- | --1.5M |
| Investing cash flow | -110.10%-121K | ---16K | ---58K | ---3K | ---44K | -14.30%1.2M | -2,125.00%-445K | 5,560.00%1.37M | --0 | 2,430.26%1.4M |
| Financing cash flow | ||||||||||
| Net issuance payments of debt | -235.27%-3.08M | ---36K | ---37K | ---1.28M | -745.15%-1.73M | 1,997.67%2.28M | -27.27%-42K | 657.58%184K | --268K | 14.24%-120.07K |
| Net common stock issuance | ---- | ---- | ---- | ---- | ---- | 0.53%1.51K | --0 | --0 | --1K | --1.5K |
| Increase or decrease of lease financing | 28.76%-181K | ---38K | ---43K | ---50K | 13.79%-50K | 17.53%-254.06K | 39.19%-45K | 12.50%-42K | ---58K | -38.77%-308.08K |
| Net other fund-raising expenses | 1,564.33%1.97M | ---19K | --0 | --2M | 33.33%-6K | -44,590.43%-134.81K | ---8K | ---1K | ---9K | 103.03%303 |
| Financing cash flow | -168.16%-1.29M | ---93K | ---80K | --669K | -983.66%-1.79M | 543.57%1.89M | 11.21%-95K | 225.89%141K | --202K | -5.79%-426.34K |
| Net cash flow | ||||||||||
| Beginning cash position | 24.15%24.38M | --19.18M | --19.8M | --20.69M | 5.95%24.38M | 67.87%19.63M | 68.57%18.9M | 18.79%16.72M | --23.01M | -27.30%11.7M |
| Current changes in cash | -302.04%-8.62M | ---3.42M | ---616K | ---889K | 41.29%-3.69M | -46.26%4.27M | 513.35%1.58M | 176.28%2.18M | ---6.29M | 311.52%7.94M |
| Effect of exchange rate changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| End cash Position | -34.07%15.76M | --15.76M | --19.18M | --19.8M | 23.71%20.69M | 21.73%23.9M | 34.54%20.48M | 68.57%18.9M | --16.72M | 8.98%19.63M |
| Free cash flow | -1,439.05%-7.33M | ---3.33M | ---536K | ---1.56M | 70.63%-1.91M | -92.03%547.4K | 702.55%1.66M | 124.33%669K | ---6.49M | 194.36%6.86M |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.